Transdermal patch platform enabling passive, truly needle‑free delivery of large‑molecule drugs (recombinant proteins and peptides) to replace daily injections. Targets patients needing basal insulin for diabetes/prediabetes, growth‑hormone and hormone‑replacement therapies, and licenses the delivery technology to pharmaceutical partners.